Top Markets
#1 Black Phoenix Black Phoenix +355.57%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.07%
#4 Akedo Akedo +52.17%
#5 Acurast Acurast +34.63%
#6 BasedHype BasedHype +25.79%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.14%
#8 Cryptopia Cryptopia +21.54%
#9 Avantis Avantis +21.13%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +16.89%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Pathfinder Cell Therapy, Inc. Pathfinder Cell Therapy, Inc.

Pathfinder Cell Therapy, Inc.

PFND
Rangering i aksjer #40886
Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in... Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in regenerative medicine. This company is dedicated to pioneering innovative cell-based and associated treatments designed to address a range of illnesses and health issues, particularly those involving localized cellular injury within organs. Its proprietary technology shows promise for tackling conditions such as diabetes, kidney disease, heart attacks (myocardial infarction), and peripheral vascular ailments, among others. Established in 2008, the company maintains its corporate headquarters in Cambridge, Massachusetts.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-12
Markedsverdi
$66.72K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Pathfinder Cell Therapy, Inc. (PFND)

Kategori

Healthcare
Inntekter for Pathfinder Cell Therapy, Inc. (PFND)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Pathfinder Cell Therapy, Inc. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Pathfinder Cell Therapy, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE